Companies · Hospitals and Physicians

Advantia Holdings LLC

ARLINGTON · Hospitals and Physicians

Diligence memoA one-page analyst read on Advantia Holdings LLC — recommendation, valuation, rhythm, risks.
$212.1M
Total raised · real
14
Rounds
5.0×
Latest step-up
Top 3%
Sector rank · raised
Series C
Latest stage · inferred · Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Advantia Holdings LLC has raised $212M over 14 rounds; too few niche peers to rank its valuation yet.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health services sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Active
  • Last raise 14 mo ago; this sector typically re-raises about every 12 months.
  • Raising on or ahead of the sector's normal rhythm.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Advantia Holdings LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
11.8 yr record
Peak capital year was 2023 with $82.7M across 1 filings.
Market position
ahead of 98% of Hospitals and Physicians peers
Capital scale is ahead of 98% of Hospitals and Physicians peers; modeled value is above 63% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2023: $82.7M across 1 filings.
  • Largest single filing was $82.7M on 2023-12-29.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Hospitals and Physicians

Advantia Holdings LLC is one of 599 Hospitals and Physicians companies tracked from ARLINGTON. By capital raised it ranks among the largest (ahead of 98% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
3
Investors (latest)
2025-04-21
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries A · 2014-09-02 Raised $4.6M (real) Modeled valuation $86M (est)Series A2014Series A · 2015-02-09 Raised $1.6M (real) Modeled valuation $31M (est)Series A2015Series A · 2016-01-07 Raised $9.6M (real) Modeled valuation $179M (est)Series A2016Series A · 2016-09-07 Raised $3.6M (real) Modeled valuation $68M (est)Series A2016Series B · 2018-01-29 Raised $20M (real) Modeled valuation $412M (est)Series B2018Series B · 2018-10-30 Raised $12M (real) Modeled valuation $257M (est)Series B2018Series B · 2019-02-01 Raised $9.5M (real) Modeled valuation $195M (est)Series B2019Series B · 2019-02-15 Raised $11M (real) Modeled valuation $226M (est)Series B2019Series B · 2019-08-14 Raised $3.1M (real) Modeled valuation $63M (est)Series B2019Series C · 2019-11-15 Raised $45M (real) Modeled valuation $957M (est)Series C2019Series C · 2023-12-29 Raised $83M (real) Modeled valuation $766M (est)Series C2023Series C · 2024-06-26 Raised $3.0M (real) Modeled valuation $25M (est)Series C2024Series C · 2024-10-30 Raised $1.0M (real) Modeled valuation $7.6M (est)Series C2024Series C · 2025-04-21 Raised $5.0M (real) Modeled valuation $34M (est)Series C2025Cumulative $212M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$4.6M · 2014
Series A extension$1.6M · 2015
Series A extension$9.6M · 2016
Series A extension$3.6M · 2016
Series B$20.0M · 2018
Series B extension$12.5M · 2018
Series B extension$9.5M · 2019
Series B extension$11.0M · 2019
Series B extension$3.1M · 2019
Series C$45.0M · 2019
Series C extension$82.7M · 2023
Series C extension$3.0M · 2024
Series C extension$1.0M · 2024
Series C extension$5.0M · 2025

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 60%.

Modeled valuation trajectory
$33.6M
Base estimate est.
$18.8M
Conservative case
$45.7M
Upside case
$33.1M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health services sector profile. Directional, not a quoted figure.

Series A · modeled $86.3M · 2014-09-022014Series A · modeled $30.5M · 2015-02-09Series A · modeled $179.2M · 2016-01-07Series A · modeled $68.3M · 2016-09-07Series B · modeled $412.1M · 2018-01-29Series B · modeled $257.1M · 2018-10-30Series B · modeled $195.0M · 2019-02-01Series B · modeled $226.5M · 2019-02-15Series B · modeled $62.8M · 2019-08-14Series C · modeled $956.8M · 2019-11-15Series C · modeled $765.8M · 2023-12-29Series C · modeled $24.7M · 2024-06-26Series C · modeled $7.6M · 2024-10-30Series C · modeled $33.6M · 2025-04-212025
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
76%
Survival probability
57% low · 88% high
1.27×/yr
Annual markup
1.46×/yr upside case
1.2 yr
Elapsed time used
1.2 yr actual, capped for stale marks
health services
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
10 mo
Avg between rounds
$19.9M/yr
Capital velocity
11.8 yr
On record since
2014
First round
14
Rounds on file
How it compares to the market

Benchmarked against 599 companies in Hospitals and Physicians. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 117× above median
This company$212.1M
Sector median$1.8M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.1× of median
This company$5.0M
Sector median$45.1M
Modeled value — vs sector median (estimate, all stages) 1.5× above median
This company$33.6M
Sector median$22.9M

Raised more than 98% of sector peers (real $). Modeled value above 63% of peers (estimate).

Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$4.6M2014-09-02$20.9M$86.3M85%
Series A$1.6M2015-02-09$7.4M$30.5M85%
Series A$9.6M2016-01-07$43.4M$179.2M85%
Series A$3.6M2016-09-07$16.5M$68.3M85%
Series B$20.0M2018-01-29$111.1M$412.1M90%
Series B$12.5M2018-10-30$69.3M$257.1M90%
Series B$9.5M2019-02-01$52.6M$195.0M90%
Series B$11.0M2019-02-15$61.1M$226.5M90%
Series B$3.1M2019-08-14$16.9M$62.8M90%
Series C$45.0M2019-11-15$300.0M$956.8M90%
Series C$82.7M2023-12-29$551.5M$765.8M90%
Series C$3.0M2024-06-26$20.0M$24.7M90%
Series C$1.0M2024-10-30$6.7M$7.6M90%
Series C$5.0M2025-04-21$33.1M$33.6M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$4.6M2014-09-02
    • First recorded raise — entered as Series A.
    • 33 investors on this round.
  2. Series A$1.6M2015-02-09
    • Came back fast: 5 mo vs the ~12 mo sector norm.
    • Round 2.8× smaller than the prior — bridge or down round.
    • 8 investors on this round.
  3. Series A$9.6M2016-01-07
    • Raised 11 mo later, in step with the ~12 mo sector norm.
    • Round 5.9× larger than the prior — scaling up.
    • 16 investors on this round.
  4. Series A$3.6M2016-09-07
    • Raised 8 mo later, in step with the ~12 mo sector norm.
    • Round 2.6× smaller than the prior — bridge or down round.
    • 25 investors on this round.
  5. Series B$20.0M2018-01-29
    • Raised 17 mo later, in step with the ~12 mo sector norm.
    • Round 5.5× larger than the prior — scaling up.
    • 1 investor on this round.
  6. Series B$12.5M2018-10-30
    • Raised 9 mo later, in step with the ~12 mo sector norm.
    • Round 1.6× smaller than the prior — bridge or down round.
    • 14 investors on this round.
  7. Series B$9.5M2019-02-01
    • Came back fast: 3 mo vs the ~12 mo sector norm.
    • Round 1.3× smaller than the prior — bridge or down round.
    • 12 investors on this round.
  8. Series B$11.0M2019-02-15
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 23 investors on this round.
  9. Series B$3.1M2019-08-14
    • Came back fast: 6 mo vs the ~12 mo sector norm.
    • Round 3.6× smaller than the prior — bridge or down round.
    • 4 investors on this round.
  10. Series C$45.0M2019-11-15
    • Came back fast: 3 mo vs the ~12 mo sector norm.
    • Round 14.8× larger than the prior — scaling up.
    • 1 investor on this round.
  11. Series C$82.7M2023-12-29
    • Raised again after 49 mo — slower than the ~12 mo sector norm.
    • Round 1.8× larger than the prior — scaling up.
    • 3 investors on this round.
  12. Series C$3.0M2024-06-26
    • Came back fast: 6 mo vs the ~12 mo sector norm.
    • Round 27.6× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  13. Series C$1.0M2024-10-30
    • Came back fast: 4 mo vs the ~12 mo sector norm.
    • Round 3.0× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  14. Series C$5.0M2025-04-21
    • Came back fast: 6 mo vs the ~12 mo sector norm.
    • Round 5.0× larger than the prior — scaling up.
    • 3 investors on this round.
Intelligence
2026 ~Q1
Modeled next raise · ~10mo cadence
$14.9M
Modeled next size est.range $9.7M$23.8M
5.0×
Last step-up
$19.9M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Richard Foster5 other2016-01
Sean Glass3 other2014-09
Jeffrey Kindler2 other2016-01
Ian Koons1 other2019-08
Jay A. Martus1 other2016-01
Leslie Henshaw1 other2018-01
Marc Solomon1 other2015-02
Mary Langowski1 other2018-01
Ameya Agge2019-11
Angela Wayne2023-12
Angie A. Teates2016-01
Bede Broome2023-12
Brent A. Westhoven2016-09
Brent Westhoven2018-01
Cynthia A. Blendu2016-09
Dale Scholler2019-08
Donna A. Nowak2016-01
Donna Nowak2019-08
Farinaz Tehrani2019-11
Gilbert Goldbeck2019-08
James Pieri2019-11
Jeff Goldberg2023-12
Jeffrey Dale Kindler2015-02
Jo'Ann Jackson2023-12
Registry & provenance

Advantia Holdings LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1619307
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Terns Pharmaceuticals, Inc.PharmaceuticalsSeries C$97.7M$2.9Bnetwork1 shared operator · same stage
Pioneer Health Systems LLCHospitals and PhysiciansSeries C$46.0M$19.3Msame sector · same stage
vTv Therapeutics Inc.PharmaceuticalsSeries C$80.5M$502.3Mnetwork1 shared operator · same stage
Sdg Holding Company, LlcHospitals and PhysiciansSeries D+$140.9M$30.5Msame sector
Rennova Health, Inc.Hospitals and PhysiciansSeries B$120.0M$19.1Msame sector
Transformer TX Holdings, LLCHospitals and PhysiciansGrowth/Late$629.0M$41.3Msame sector
Whiteglove House Call Health IncHospitals and PhysiciansSeries B$65.3M$30.9Msame sector
Village Practice Management Company, LLCHospitals and PhysiciansGrowth/Late$1.1B$23.0Msame sector
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
MedVanta, LLCHospitals and PhysiciansSeries A$7.5M89%
Advocatia Solutions, Inc.Other Health CareSeed$28.2M81%
Advanta Health Solutions, Inc.HealthtechPre-Seed$2.8M81%
Apm Holdings, LlcHospitals and PhysiciansPre-Seed$8.3M80%
CTVSA Holdings, LLCHospitals and PhysiciansPre-Seed$2.5M79%
AJR Physician Holdings, LLCHospitals and PhysiciansPre-Seed$10.3M79%
Lighthouse Surgery Holdings, LlcHospitals and PhysiciansSeed$34.9M79%
Africa Health Holdings LtdHospitals and PhysiciansSeries A$262.3M78%
Frequently asked
How much funding has Advantia Holdings LLC raised?
Advantia Holdings LLC has raised approximately $212.1M in disclosed capital across 14 recorded financing rounds, aggregated from public filings.
What is Advantia Holdings LLC's estimated valuation?
Provath's modeled valuation for Advantia Holdings LLC is approximately $33.6M (modeled range $18.8M–$45.7M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Advantia Holdings LLC at?
Advantia Holdings LLC's latest modeled financing stage is Series C. Its most recent recorded round closed around Mon Apr 21.
What does Advantia Holdings LLC do and where is it based?
Advantia Holdings LLC operates in the Hospitals and Physicians sector, based in ARLINGTON.
Explore related

See where Advantia Holdings LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Advantia Holdings LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.